A method has been developed to prevent end-stage renal disease due to diabetes or hypertension (Moskowitz D. From pharmacogenomics to improved patient outcomes: angiotensin I-converting enzyme as an example. Diabetes Technology & Therapeutics 4(4):519-532, 2002).

A medical treatment for acute oliguric renal failure has also been developed, which avoids the need for dialysis in approximately three-quarters of cases (unpublished). Both methods are patent-protected. Both treatment methods are obviously ideal in situations where dialysis is unavailable, as in earthquakes, or in Third World countries.

Even developed countries where chronic dialysis is rationed, as in the UK, would obviously benefit. Patients, of course, in every country would love to avoid dialysis if at all possible, although nephrologists do not appear to be of the same mind. Anybody desiring further information is encouraged to contact the author.